vs

Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and SunCoke Energy, Inc. (SXC). Click either name above to swap in a different company.

SunCoke Energy, Inc. is the larger business by last-quarter revenue ($480.2M vs $268.1M, roughly 1.8× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 1.4% vs -17.8%, a 19.2% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.7% vs -1.2%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (5.3% CAGR vs -0.8%).

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.

Energy Brands, also doing business as Glacéau, is a privately owned subsidiary of the Coca-Cola Company based in Whitestone, Queens, New York, that manufactures and distributes various lines of drinks marketed as enhanced water. Founded in May 1996 by J. Darius Bikoff with an electrolyte enhanced line of water called Smartwater, Energy Brands initially distributed its products to health food stores and independent retailers in the New York area. Adding Fruitwater and Vitaminwater to its line ...

ACAD vs SXC — Head-to-Head

Bigger by revenue
SXC
SXC
1.8× larger
SXC
$480.2M
$268.1M
ACAD
Growing faster (revenue YoY)
ACAD
ACAD
+10.9% gap
ACAD
9.7%
-1.2%
SXC
Higher net margin
ACAD
ACAD
19.2% more per $
ACAD
1.4%
-17.8%
SXC
Faster 2-yr revenue CAGR
ACAD
ACAD
Annualised
ACAD
5.3%
-0.8%
SXC

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ACAD
ACAD
SXC
SXC
Revenue
$268.1M
$480.2M
Net Profit
$3.6M
$-85.6M
Gross Margin
Operating Margin
-1.7%
-20.4%
Net Margin
1.4%
-17.8%
Revenue YoY
9.7%
-1.2%
Net Profit YoY
-461.2%
EPS (diluted)
$0.02
$-1.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACAD
ACAD
SXC
SXC
Q1 26
$268.1M
Q4 25
$284.0M
$480.2M
Q3 25
$278.6M
$487.0M
Q2 25
$264.6M
$434.1M
Q1 25
$244.3M
$436.0M
Q4 24
$259.6M
$486.0M
Q3 24
$250.4M
$490.1M
Q2 24
$242.0M
$470.9M
Net Profit
ACAD
ACAD
SXC
SXC
Q1 26
$3.6M
Q4 25
$273.6M
$-85.6M
Q3 25
$71.8M
$22.2M
Q2 25
$26.7M
$1.9M
Q1 25
$19.0M
$17.3M
Q4 24
$143.7M
$23.7M
Q3 24
$32.8M
$30.7M
Q2 24
$33.4M
$21.5M
Gross Margin
ACAD
ACAD
SXC
SXC
Q1 26
Q4 25
90.8%
Q3 25
92.2%
Q2 25
92.2%
Q1 25
91.7%
Q4 24
91.6%
Q3 24
92.5%
Q2 24
92.5%
Operating Margin
ACAD
ACAD
SXC
SXC
Q1 26
-1.7%
Q4 25
6.1%
-20.4%
Q3 25
12.8%
2.8%
Q2 25
12.2%
2.3%
Q1 25
7.9%
6.9%
Q4 24
59.1%
7.3%
Q3 24
12.6%
9.6%
Q2 24
12.6%
7.4%
Net Margin
ACAD
ACAD
SXC
SXC
Q1 26
1.4%
Q4 25
96.3%
-17.8%
Q3 25
25.8%
4.6%
Q2 25
10.1%
0.4%
Q1 25
7.8%
4.0%
Q4 24
55.4%
4.9%
Q3 24
13.1%
6.3%
Q2 24
13.8%
4.6%
EPS (diluted)
ACAD
ACAD
SXC
SXC
Q1 26
$0.02
Q4 25
$1.61
$-1.00
Q3 25
$0.42
$0.26
Q2 25
$0.16
$0.02
Q1 25
$0.11
$0.20
Q4 24
$0.86
$0.28
Q3 24
$0.20
$0.36
Q2 24
$0.20
$0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACAD
ACAD
SXC
SXC
Cash + ST InvestmentsLiquidity on hand
$88.7M
Total DebtLower is stronger
$685.5M
Stockholders' EquityBook value
$597.3M
Total Assets
$1.6B
$1.8B
Debt / EquityLower = less leverage
1.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACAD
ACAD
SXC
SXC
Q1 26
Q4 25
$177.7M
$88.7M
Q3 25
$258.0M
$80.4M
Q2 25
$253.6M
$186.2M
Q1 25
$217.7M
$193.7M
Q4 24
$319.6M
$189.6M
Q3 24
$155.1M
$164.7M
Q2 24
$177.1M
$81.9M
Total Debt
ACAD
ACAD
SXC
SXC
Q1 26
Q4 25
$685.5M
Q3 25
$691.1M
Q2 25
$493.4M
Q1 25
$492.9M
Q4 24
$492.3M
Q3 24
$491.8M
Q2 24
$491.3M
Stockholders' Equity
ACAD
ACAD
SXC
SXC
Q1 26
Q4 25
$1.2B
$597.3M
Q3 25
$917.3M
$695.9M
Q2 25
$822.4M
$677.7M
Q1 25
$765.2M
$684.6M
Q4 24
$732.8M
$680.2M
Q3 24
$577.2M
$658.6M
Q2 24
$516.7M
$636.9M
Total Assets
ACAD
ACAD
SXC
SXC
Q1 26
$1.6B
Q4 25
$1.6B
$1.8B
Q3 25
$1.3B
$1.9B
Q2 25
$1.2B
$1.6B
Q1 25
$1.1B
$1.7B
Q4 24
$1.2B
$1.7B
Q3 24
$976.9M
$1.7B
Q2 24
$914.1M
$1.7B
Debt / Equity
ACAD
ACAD
SXC
SXC
Q1 26
Q4 25
1.15×
Q3 25
0.99×
Q2 25
0.73×
Q1 25
0.72×
Q4 24
0.72×
Q3 24
0.75×
Q2 24
0.77×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACAD
ACAD
SXC
SXC
Operating Cash FlowLast quarter
$56.6M
Free Cash FlowOCF − Capex
$32.8M
FCF MarginFCF / Revenue
6.8%
Capex IntensityCapex / Revenue
5.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$42.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACAD
ACAD
SXC
SXC
Q1 26
Q4 25
$-48.7M
$56.6M
Q3 25
$74.3M
$9.2M
Q2 25
$64.0M
$17.5M
Q1 25
$20.3M
$25.8M
Q4 24
$40.4M
$60.9M
Q3 24
$63.2M
$107.2M
Q2 24
$25.0M
$-9.3M
Free Cash Flow
ACAD
ACAD
SXC
SXC
Q1 26
Q4 25
$32.8M
Q3 25
$73.9M
$-16.3M
Q2 25
$4.9M
Q1 25
$20.9M
Q4 24
$36.1M
Q3 24
$63.2M
$92.1M
Q2 24
$-26.8M
FCF Margin
ACAD
ACAD
SXC
SXC
Q1 26
Q4 25
6.8%
Q3 25
26.5%
-3.3%
Q2 25
1.1%
Q1 25
4.8%
Q4 24
7.4%
Q3 24
25.2%
18.8%
Q2 24
-5.7%
Capex Intensity
ACAD
ACAD
SXC
SXC
Q1 26
Q4 25
5.0%
Q3 25
0.1%
5.2%
Q2 25
2.9%
Q1 25
1.1%
Q4 24
5.1%
Q3 24
0.0%
3.1%
Q2 24
3.7%
Cash Conversion
ACAD
ACAD
SXC
SXC
Q1 26
Q4 25
-0.18×
Q3 25
1.03×
0.41×
Q2 25
2.40×
9.21×
Q1 25
1.07×
1.49×
Q4 24
0.28×
2.57×
Q3 24
1.93×
3.49×
Q2 24
0.75×
-0.43×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons